Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Competition Intensifies on Market for Antidepressants
April 29, 2002
- Companies' Responsibility for Promotion of Medical Safety Clarified
April 29, 2002
- We Are Open to Strategic Alliance: Mr Wright of AstraZeneca
April 29, 2002
- Hitachi Medical: Digital Ultrasound Diagnostic System
April 22, 2002
- Fujisawa Launches Protopic in Germany
April 22, 2002
- Olympus: VISERA Video System for Endoscopy
April 22, 2002
- AnGes MG Newly Agrees Agreement with Daiichi on HGF Gene Therapy
April 22, 2002
- Genzyme Promotes 4-Marker Maternal Serum Screening Test
April 22, 2002
- Nippon Roche, Chugai to Copromote Kytril
April 22, 2002
- Takeda: HICEE WHITE 2
April 22, 2002
- BUSINESS NEWS IN BRIEF
April 22, 2002
- Hac Kimisawa: Sales Up 6.7% to \144 Bil.
April 22, 2002
- WLJ: FY2001 Sales Up 8.8% to \46.2 Bil.
April 22, 2002
- Kirindo: Consolidated Sales Jump to \33 Bil.
April 22, 2002
- Teijin: Drug Sales, Profits to Plummet in FY2002
April 22, 2002
- WORLD NEWS IN BRIEF
April 22, 2002
- Hisamitsu: FY2001 Sales Up 6.6% to \69.5 Bil.
April 22, 2002
- Bayer Group to Increase Sales in Japan to \300 Bil. by 2004: Dr Portoff
April 22, 2002
- Pharmacia Starts Joint Research with Keio Univ.
April 22, 2002
- Pharmaceutical Industry Vision Drafted by Korosho
April 22, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…